Showing 911-920 of 1046 results for "".
- Allergan to Present New Data on Investigational Medicines at AAOhttps://modernod.com/news/allergan-to-present-new-data-on-investigational-medicines-at-aao/2479768/Allergan will present new data at the annual meeting of the American College of Ophthalmology (AAO) to be held in Chicago. The Retina Subspecialty Day (October 26-27) will feature two late-breaker presentations on the
- ImprimisRx to Feature New Formulation and Poster Presentation on MKO Melt at AAO Meeting in Chicagohttps://modernod.com/news/imprimisrx-to-feature-new-formulation-and-poster-presentation-on-mko-melt-at-aao-meeting-in-chicago/2479781/ImprimisRx announced its participation at the upcoming 2018 American Academy of Ophthalmology (AAO) annual meeting to be held at the McCormick Place Convention Center in Chicago, October 26-30. At the conference, attendees will have the opportunity to meet with ImprimisRx representatives
- Researchers Discover Therapeutic Target to Aid in Glaucoma Treatmenthttps://modernod.com/news/researchers-discover-therapeutic-target-to-aid-in-glaucoma-treatment/2481470/Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma, according to an article posted on the university website.
- International Sports Vision Association and Macuhealth Offer New Educational Resource on Sports Nutrition for Your Eyeshttps://modernod.com/news/international-sports-vision-association-and-macuhealth-offer-new-educational-resource-on-sports-nutrition-for-your-eyes/2479270/The International Sports Vision Association (ISVA) and MacuHealth announced the launch of “Sports Nutrition for Your Eyes,” a new educational resource on the ISVA website designed to help educate athletes about how proper nutrition ca
- Novartis Implementing Programs to Assist Optometrists During COVID-19https://modernod.com/news/novartis-implementing-programs-to-assist-optometrists-during-covid-19/2477609/Novartis announced that it is implementing the following to ensure optometrists are well-equipped to provide care for patients during the COVID-19 pandemic: Strengthening the online, self-service sample website –
- New Guidance Issued on Paycheck Protection Program Loanshttps://modernod.com/news/new-guidance-issued-on-ppp-loans/2477525/New guidance was posted to the Treasury website regarding the Paycheck Protection Program (PPP), which authorizes up to $349 billion toward job retention and certain other expenses for s
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- Retina Rocks: Retina Image & Reference Library Now Available Onlinehttps://modernod.com/news/retina-rocks-retina-image-reference-library-now-available-online/2477152/Retina Rocks, a new online, collection of open-source retina teachings, is now available at retinarocks.org. The website includes 22,000 multimodal images and 3,700 annotated references that are organized alphabetically by topic into approximately 360 sections
- Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harderhttps://modernod.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women. But experts don’t know why. At Johns Hopkins University, researchers have begun to
- Staar Surgical Announces Leadership Changeshttps://modernod.com/news/staar-surgical-announces-leadership-changes/2482682/Staar Surgical announced that Stephen C. Farrell, current Lead Independent Director of the Staar Board of Directors, has been appointed President and CEO, effective February 26, 2025. He is replacing Tom Frinzi, current President and CEO, who will remain with the company in an advisory role
